ES2101998T3 - Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica. - Google Patents

Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica.

Info

Publication number
ES2101998T3
ES2101998T3 ES93830010T ES93830010T ES2101998T3 ES 2101998 T3 ES2101998 T3 ES 2101998T3 ES 93830010 T ES93830010 T ES 93830010T ES 93830010 T ES93830010 T ES 93830010T ES 2101998 T3 ES2101998 T3 ES 2101998T3
Authority
ES
Spain
Prior art keywords
esters
pharmaceutical compositions
acilcarnitine
preparation
long chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93830010T
Other languages
English (en)
Inventor
Mose Santaniello
Maria Ornella Tinti
Domenico Misiti
Piero Foresta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2101998T3 publication Critical patent/ES2101998T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION SE REFIERE A LOS ESTERES DE LAS L-CARNITINAS DE ACILO DE FORMULA GENERAL (I): EN DONDE R ES UN GRUPO ACILO RECTO O RAMIFICADO QUE TIENE 2 A 16 ATOMOS DE CARBONO, EN PARTICULAR ISOBUTIRILO Y ISOVALERILO; N ES UN ENTERO COMPRENDIDO ENTRE 7 Y 15, PARTICULARMENTE 10; Y X ES EL ANION DE UN ACIDO FARMACOLOGICAMENTE ACEPTADO ESTAN DOTADOS DE UNA POTENTE ACTIVIDAD ANTIMICOTICA ESPECIALMENTE CONTRA HONGOS DEL TIPO LEVADURA, TALES COMO CANDIDA ALBICANS, EL AGENTE ETIOLOGICO DE CANDIDIASIS Y CONTRA HONGOS FILAMENTOSOS, TALES COMO ASPERGILLUS FUMIGATUS, EL AGENTE ETIOLOGICO DE LA ASPERGILOSIS. COMPOSICIONES FARMACEUTICAS POR ORAL O PARENTERALMENTE ADMINISTRABLES O TOPICAMENTE APLICABLES CONTIENEN UN ESTER DE FORMULA (I) COMO INGREDIENTE ACTIVO.
ES93830010T 1992-01-16 1993-01-15 Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica. Expired - Lifetime ES2101998T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920028A IT1254136B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Publications (1)

Publication Number Publication Date
ES2101998T3 true ES2101998T3 (es) 1997-07-16

Family

ID=11400574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93830010T Expired - Lifetime ES2101998T3 (es) 1992-01-16 1993-01-15 Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica.

Country Status (13)

Country Link
US (2) US5519056A (es)
EP (1) EP0552138B1 (es)
JP (1) JP3294652B2 (es)
KR (1) KR100251887B1 (es)
AT (1) ATE151744T1 (es)
CA (1) CA2087084C (es)
DE (1) DE69309725T2 (es)
DK (1) DK0552138T3 (es)
ES (1) ES2101998T3 (es)
GR (1) GR3023163T3 (es)
HK (1) HK1005864A1 (es)
IT (1) IT1254136B (es)
ZA (1) ZA93161B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258370B (it) * 1992-03-02 1996-02-26 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US5741816A (en) 1994-06-20 1998-04-21 Tanabe Seiyaku Co., Ltd. Hair-growth agent
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283955B1 (it) * 1996-03-20 1998-05-07 Sigma Tau Ind Farmaceuti Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596147A5 (es) * 1974-09-25 1978-02-28 Lonza Ag
CH588443A5 (es) * 1974-09-25 1977-06-15 Lonza Ag
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1170861B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1191945B (it) * 1986-06-04 1988-03-31 Avantgarde Spa N-alchilammidi della d(+)-carnitina dotate di attivita' antibatterica,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1235494B (it) * 1987-12-02 1992-09-04 Avantgarde Spa N-alchilammidi della dl e l(-)carnitina dotate di attivita' antibatterica, procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Also Published As

Publication number Publication date
JPH05339219A (ja) 1993-12-21
DE69309725D1 (de) 1997-05-22
DK0552138T3 (da) 1997-10-20
EP0552138A3 (en) 1993-10-20
ITRM920028A0 (it) 1992-01-16
EP0552138B1 (en) 1997-04-16
ITRM920028A1 (it) 1993-07-16
KR930016392A (ko) 1993-08-26
CA2087084A1 (en) 1993-07-17
ZA93161B (en) 1993-10-06
US5525627A (en) 1996-06-11
IT1254136B (it) 1995-09-08
DE69309725T2 (de) 1997-07-31
HK1005864A1 (en) 1999-01-29
ATE151744T1 (de) 1997-05-15
EP0552138A2 (en) 1993-07-21
CA2087084C (en) 2003-12-23
KR100251887B1 (ko) 2000-05-01
JP3294652B2 (ja) 2002-06-24
GR3023163T3 (en) 1997-07-30
US5519056A (en) 1996-05-21

Similar Documents

Publication Publication Date Title
ES2095566T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos.
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
AR022300A1 (es) Composicion adyuvante
GB1307644A (en) Liquid shampoos
CO4940385A1 (es) Composiciones limpiadoras liquidas suaves antimicrobianas que se quitan enjuagando surfactantes acidos
ES2093395T3 (es) Esteres de acil carnitinas con alcoholes alifaticos de cadena larga y composiciones farmaceuticas que los contienen con actividad antibacteriana.
BR0109251A (pt) Formulação agrotécnica, e, uso de um ciclo-hexanopolicarboxato de di(isononila)
BG104631A (en) Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
ES2101998T3 (es) Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica.
TR200202358T2 (tr) Farmakolojik olarak aktif bileşiklerin hücreiçi taşınması için katyonik lipidlerin kullanımı.
AR025324A1 (es) Composiciones farmaceuticas para la administracion oral y topica
ES2134232T3 (es) Agentes para limpieza y acondicionamiento de los cabellos, de la piel asi como de textiles y superficies duras.
GB1120230A (en) Germicidal compositions
AR004625A1 (es) Composicion de un oseo activo que comprende una sustancia de un oseo activo y un carrier bilogico de dicha sustancia,composicion farmaceutica que comprende dicha composicion de un oseo-activo,y uso de dicha composicion para la preparacion de un medicamento
AR023149A1 (es) Composiciones de spray para el cabello con un bajo contenido de compuestos organicos volatiles (voc) que presentan beneficios mejorados de estilizacion
GB1230413A (es)
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
MX9207344A (es) Formulaciones mejoradas que tienen mejoradores hidrofobicos de penetracion transdermica y metodo para proveerla.
JPS6413018A (en) Skin-beautifying cosmetic
BR0014117A (pt) Uso de sabÈes de acido graxo/aminoácido para aumentar a eficácia antimicrobiana de composições farmacêutica tópicas
AR076320A1 (es) Composiciones oftalmicas acuosas que contienen agentes terapeuticos anionicos
MXPA03010673A (es) Compsiciones antitranspirantes presurizadas que contienen el propelente dimetileter y un solvente de baja polaridad.
GB1473318A (en) Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
MD1471G2 (ro) Remediu medicamentos antibacterian şi antimicotic
CA1206881A (en) Anti seborrhoeic composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 552138

Country of ref document: ES